Whitepapers

Sep 29, 2016
Pharmaceutical Executive
Biopharma companies face significant complexity. This insight brief will help you learn how to align all aspects of marketed product maintenance (including regulatory, safety and benefit-risk management) to improve compliance and reduce complexity and cost.
Sep 29, 2016
Pharmaceutical Executive
View this infographic to see how Quintiles helps anticipate and address the complex challenges of rare disease studies by bringing together a specialized team with rare disease experience and therapeutic expertise, along with tailored patient-centric approaches to global study planning and execution in order to speed treatments to market to transform the lives of patients and their families
Sep 29, 2016
Pharmaceutical Executive
Quintiles is an experienced partner who can help biopharmaceutical companies simplify the complexities of rare disease studies to speed new treatments to market for patients and their families. Read this compendia featuring blogs and bylined articles from Quintiles’ experts to learn more.
Sep 27, 2016
Pharmaceutical Executive
Join Randolph Carpio from Quintiles, and Joe Bonaccorso from Pierre Fabre as they discuss the importance of getting the reimbursement, access and distribution strategy correct to make the most of the opportunities in the U.S.
Sep 22, 2016
Sponsored Content
Hundreds of new vaccines are in clinical development, yet significant barriers to progress exist. These barriers include a lack of novel approaches to help speed timelines and drive efficiencies in clinical testing of vaccines and the need for reduced R&D cost to improve the ROI of vaccine development globally. Read this fact sheet to see how Quintiles’ dedicated team of vaccine experts can help drive your vaccine studies forward.
Sep 21, 2016
Sponsored Content
This paper, which incorporates the results of a survey of 254 pharmaceutical executives worldwide and a range of interviews with industry experts, explores global pharmaceutical companies' growth strategies and their plans for managing the associated risks.
Sep 21, 2016
Sponsored Content
This paper, which incorporates the results of a survey of 254 pharmaceutical executives worldwide and a range of interviews with industry experts, explores global pharmaceutical companies' growth strategies and their plans for managing the associated risks.
Sep 06, 2016
Sponsored Content
In the global life sciences marketplace, the ability to rapidly identify and capitalize on emerging technologies is a critical marker for success. This whitepaper describes how Meta uses world-leading machine intelligence to enable complete, continual, and unbiased awareness of the advances and technologies that will change industries, years in advance.
Sep 01, 2016
Sponsored Content
Many clinical trials rely on clinician-administered assessments, which are subject to variability and error. MedAvante’s research has shown that electronic clinician outcome assessments (eCOA) administered with the Virgil platform demonstrate substantially reduced error rates compared to paper-based assessments. Using eCOA can standardize assessments and reduce error, thereby strengthening signal detection.
Sep 01, 2016
Sponsored Content
Vaccines are one of the most efficacious health investments in history at preventing widespread infectious diseases and reducing human mortality. However, with more than 450 vaccines in development, only one in 10 will reach the populations that need them. You need one global partner to help transform your vaccine development programs. Learn more at www.quintiles.com/vaccines.
native1_300x100
lorem ipsum